The use of standardised structured radiology reports improves the consistency, reproducibility and overall quality of radiological reporting while enhancing communication with referring physicians and ultimately contributing to improved patient care. To develop a standardised structured report template for foetal and neonatal postmortem magnetic resonance imaging through expert consensus. A Delphi survey was conducted between September and December 2025 among members of the ESPR Postmortem Task Force and other recommended international PM imaging experts. The surveyed items were derived from clinically used MRI reporting templates across the expert group. Consensus was defined using a ≥75
Postmortem imaging (PMI) following fetal, perinatal, and pediatric demise is increasingly requested and used in clinical practice, either as a non-invasive adjunct or alternative to conventional autopsy. Use of such techniques in clinical departments may face numerous barriers and challenges, varying between centers, countries, and continents, influenced by differences in healthcare systems, funding sources, and local regulations. Furthermore, different issues arise for each specific indication of pediatric PMI (such as intra-uterine demise, termination of pregnancy for confirmation of anatomical abnormalities, and forensic investigations of infants and childhood deaths) since the processes, goals of the investigation, and involved teams vary with indication and/or resource setting. This multi-society position statement describes how different countries currently deal with those challenges, and proposes universal consensus recommendations, enablers, and practical tips to facilitate the successful implementation of fetal and pediatric PMI across medical imaging departments. Implementation to a minimum standard will help resource allocation, collaboration between centers, and multi-center studies in a new field where patient data is scarce.
Background: The Toumai™ robotic system (MicroPort® MedBot™) is a multiport platform with CE marking for endoscopic procedures in several surgical specialties. To date, clinical experience with robot-assisted radical prostatectomy (RARP) remains limited to a small number of reported cases, with no large or comparative series available. Transitioning to a new robotic platform presents regulatory, logistical, and financial challenges. Further studies are required to evaluate its safety, efficacy, and surgical performance. We aimed to evaluate the feasibility and safety of RARP with the second-generation Toumai™ (MT1000) and describe its key features for centers considering this technology. Materials and methods: A prospective case series of RARP in patients with localized prostate cancer was performed using the Toumai™ MT1000 platform. The primary objective was to evaluate the feasibility and safety of the novel robotic system. The secondary objective was to characterize perioperative variables. Results: Fifty patients were included in the final analysis. All surgeries were completed without conversion or intraoperative complications. One patient experienced a postoperative non-urological complication requiring reoperation, and another developed acute urinary retention. The median age was 65 years (interquartile range [IQR]: 8.5), body mass index was 27.1 kg/m 2 (IQR: 5.1), and 96% were ASA I–II. Median docking time was 7.5 minutes (IQR: 7), console time 165 minutes (IQR: 50), and total OT 190 minutes (IQR: 65). Median estimated blood loss was 200 mL (IQR: 237), length of hospital stay 2 days (IQR: 1), and catheter duration 7 days (IQR: 1). Seventy percent were pT2, and 30% pT3, with an 18% positive margin rate. Minor issues included rebooting the patient cart in 6% of cases and replacing scissors in 4% of procedures. We analyzed our data by tertiles to assess the learning curve and found no significant changes over time, except for console time, which increased (median of 180, 190, and 220 minutes), and the PSM, which decreased (25%, 20%, and 13.3%). Conclusions: This study presents an initial, non-comparative, single-center experience with the Toumai™ robotic system for RARP, demonstrating its feasibility and safety in a limited cohort. Additionally, it provides valuable insights to assist medical centers and surgeons interested in adopting this technology.
BACKGROUND:Hallux valgus is associated with pain, functional limitation and reduced life quality. Percutaneous surgical techniques with multimodal analgesia have emerged as alternatives to conventional approaches. Some studies suggest that percutaneous techniques result in less pain than open surgery. PURPOSE:To compare rescue analgesic use and postoperative pain between the Scarf and META techniques in patients undergoing hallux valgus surgery. METHODS:A prospective cohort comprising two matched groups of patients who underwent hallux valgus surgery with either the Scarf or META technique was conducted. The same anesthetic and analgesic protocol was used in both groups. Pain was assessed using the Visual Analog Scale (VAS). Surveys were administered daily from postoperative day 1 to 7 and weekly from the second to the sixth week. Rescue analgesia (opioids) was also recorded. RESULTS:53 patients were enrolled: 28 in the META and 25 in the Scarf osteotomy group; demographic data were similar between groups. On postoperative day 1, VAS pain was 0.5 (0-2) in the META group and 2 (0-5) in the Scarf group. On day 2, it was 1 (0-2) and 7.1,3-10 respectively. By week 6, pain were similar in both groups. Opioid use was higher in the open group. Differences in pain and analgesic use were statistically significant (p < 0.05). CONCLUSION:The percutaneous group required lower doses of analgesia and reported less pain than the open technique, particularly during the first two postoperative weeks.
Targetoid liver lesions exhibit a characteristic MRI appearance, with differential signal intensity and enhancement between the central and peripheral components. This imaging pattern is observed across a wide range of benign, malignant, infectious, inflammatory, and vascular conditions. This educational pictorial essay aims to familiarize radiologists with the MRI spectrum of targetoid hepatic lesions and to introduce a practical diagnostic algorithm that integrates imaging findings with clinical context, thereby enhancing diagnostic accuracy in complex cases. MRI protocols include dynamic multiphase contrast-enhanced imaging with extracellular or hepatobiliary contrast agents, along with T2-weighted and diffusion-weighted sequences. Key imaging features, such as rim arterial-phase enhancement, delayed central enhancement, T2 target appearance, Targetoid appearence in diffusion restriction, and Targetoid appearance in the Transitional phase or Hepatobiliary phase with hepatobiliary contrast agents, are highlighted. By employing this structured approach, radiologists can interpret targetoid liver lesions with greater confidence and systematic precision, thereby supporting timely diagnosis and appropriate patient management.
